IPO Gives Kyverna Cash To Maintain Lead In Autoimmune CAR-T Development

With Metagenomi And Telomir, US Offerings Total Seven

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.